Abstract
Cancer is a multi-faceted disease in which spontaneous mutation(s) in a cell leads to the growth and development of a malignant new organ that if left undisturbed will grow in size and lead to eventual death of the organism. During this process, multiple cell types are continuously releasing signaling molecules into the microenvironment, which results in a tangled web of communication that both attracts new cell types into and reshapes the tumor microenvironment as a whole. One prominent class of molecules, chemokines, bind to specific receptors and trigger directional, chemotactic movement in the receiving cell. Chemokines and their receptors have been demonstrated to be expressed by almost all cell types in the tumor microenvironment, including epithelial, immune, mesenchymal, endothelial, and other stromal cells. This results in chemokines playing multifaceted roles in facilitating context-dependent intercellular communications. Recent research has started to shed light on these ligands and receptors in a cancer-specific context, including cell-type specificity and drug targetability. In this review, we summarize the latest research with regards to chemokines in facilitating communication between different cell types in the tumor microenvironment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahirwar DK, Nasser MW, Ouseph MM et al (2018) Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene 37:4428–4442. https://doi.org/10.1038/s41388-018-0263-7
Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787–820. https://doi.org/10.1146/annurev.immunol.24.021605.090529
Angiolillo AL, Sgadari C, Taub DD et al (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182:155–162. https://doi.org/10.1084/jem.182.1.155
Araujo JM, Gomez AC, Aguilar A et al (2018) Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer. Sci Rep 8:4899. https://doi.org/10.1038/s41598-018-23099-7
Awaji M, Futakuchi M, Heavican T et al (2019) Cancer-associated fibroblasts enhance survival and progression of the aggressive pancreatic tumor via FGF-2 and CXCL8. Cancer Microenviron 12:37–46. https://doi.org/10.1007/s12307-019-00223-3
Baci D, Bruno A, Cascini C et al (2019) Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies. J Exp Clin Cancer Res 38:464. https://doi.org/10.1186/s13046-019-1461-z
Bartneck M, Schrammen PL, Möckel D et al (2019) The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers. Cell Mol Gastroenterol Hepatol 7:371–390. https://doi.org/10.1016/j.jcmgh.2018.10.007
Bellinghausen I, Reuter S, Martin H et al (2012) Enhanced production of CCL18 by tolerogenic dendritic cells is associated with inhibition of allergic airway reactivity. J Allergy Clin Immunol 130:1384–1393. https://doi.org/10.1016/j.jaci.2012.08.039
Ben-Baruch A, Xu L, Young PR et al (1995) Monocyte Chemotactic Protein-3 (MCP3) interacts with multiple leukocyte receptors: C-C CKR1, a receptor for macrophage inflammatory protein-1α/RANTES, is also a functional receptor foR MCP3. J Biol Chem 270:22123–22128. https://doi.org/10.1074/jbc.270.38.22123
Benedicto A, Romayor I, Arteta B (2018) CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver. Oncol Rep 39:2022–2030. https://doi.org/10.3892/or.2018.6254
Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401–410. https://doi.org/10.1038/nrc1093
Bernard S, Myers M, Fang WB et al (2018) CXCL1 derived from mammary fibroblasts promotes progression of mammary lesions to invasive carcinoma through CXCR2 dependent mechanisms. J Mammary Gland Biol Neoplasia 23:249–267. https://doi.org/10.1007/s10911-018-9407-1
Bhagat TD, Von Ahrens D, Dawlaty M et al (2019) Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Elife. https://doi.org/10.7554/eLife.50663
Bi H, Zhang Y, Wang S et al (2019) Interleukin-8 promotes cell migration via CXCR1 and CXCR2 in liver cancer. Oncol Lett 18:4176–4184. https://doi.org/10.3892/ol.2019.10735
Bleul CC, Fuhlbrigge RC, Casasnovas JM et al (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184:1101–1109. https://doi.org/10.1084/jem.184.3.1101
Borish LC, Steinke JW (2003) 2. Cytokines and chemokines. J Allergy Clin Immunol 111:S460–S475. https://doi.org/10.1067/mai.2003.108
Brett E, Sauter M, Timmins É et al (2020) Oncogenic linear collagen VI of invasive breast cancer is induced by CCL5. J Clin Med Res: https://doi.org/10.3390/jcm9040991
Cai L, Xu S, Piao C et al (2016) Adiponectin induces CXCL1 secretion from cancer cells and promotes tumor angiogenesis by inducing stromal fibroblast senescence. Mol Carcinog 55:1796–1806. https://doi.org/10.1002/mc.22428
Cai X, Li Z, Zhang Q et al (2018) CXCL 6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD 2/BRD 4/C-MYC/EZH 2 pathway in liver fibrosis. J Cell Mol Med 22:5050–5061
(2019) CDC—Expected New Cancer Cases and Deaths in 2020. https://www.cdc.gov/cancer/dcpc/research/articles/cancer_2020.htm. Accessed 24 Jul 2020
Cecchinato V, Uguccioni M (2018) Insight on the regulation of chemokine activities. J Leukoc Biol 104:295–300. https://doi.org/10.1002/JLB.3MR0118-014R
Chen X, Wang Y, Nelson D et al (2016) CCL2/CCR2 regulates the tumor microenvironment in HER-2/neu-driven mammary carcinomas in mice. PLoS ONE 11:e0165595. https://doi.org/10.1371/journal.pone.0165595
Chen K, Liu Q, Tsang LL et al (2017) Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway. Cell Death Dis 8:e2819. https://doi.org/10.1038/cddis.2017.138
Chen S-J, Lian G, Li J-J et al (2018) Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8. Cancer Med 7:5679–5690. https://doi.org/10.1002/cam4.1824
Chen C, Xu Z-Q, Zong Y-P et al (2019) CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer. Cell Death Dis 10:178. https://doi.org/10.1038/s41419-019-1431-6
Chen J, Tan L, Liao Y, et al (2020) Chemokine CCL2 impairs spatial memory and cognition in rats via influencing inflammation, glutamate metabolism and apoptosis-associated genes expression-a potential mechanism for HIV-associated neurocognitive disorder. Life Sci 117828
Choi J, Ahn SS, Lim Y et al (2018) Inhibitory effect of alisma canaliculatum ethanolic extract on NF-κB-dependent CXCR3 and CXCL10 expression in TNFα-exposed MDA-MB-231 breast cancer cells. Int J Mol Sci. https://doi.org/10.3390/ijms19092607
Chow MT, Luster AD (2014) Chemokines in cancer. Cancer. Immunol Res 2:1125–1131. https://doi.org/10.1158/2326-6066.CIR-14-0160
Chung B, Esmaeili AA, Gopalakrishna-Pillai S et al (2017) Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12. NPJ Breast Cancer 3:6. https://doi.org/10.1038/s41523-017-0008-8
Cioni B, Nevedomskaya E, Melis MHM et al (2018) Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2-and CXCL8-mediated cancer cell migration. Mol Oncol 12:1308–1323
Costa A, Kieffer Y, Scholer-Dahirel A et al (2018) Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33:463-479.e10. https://doi.org/10.1016/j.ccell.2018.01.011
Demircioglu F, Wang J, Candido J et al (2020) Cancer associated fibroblast FAK regulates malignant cell metabolism. Nat Commun 11:1290. https://doi.org/10.1038/s41467-020-15104-3
Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313–326. https://doi.org/10.1089/jir.2008.0027
Deutsch E, Johnson SA, Seegers WH (1955) Differentiation of certain platelet factors related to blood coagulation. Circ Res 3:110–115. https://doi.org/10.1161/01.res.3.1.110
Dimberg A (2010) Chemokines in angiogenesis. Curr Top Microbiol Immunol 341:59–80. https://doi.org/10.1007/82_2010_21
Dinarello CA (2007) Historical insights into cytokines. Eur J Immunol 37(Suppl 1):S34-45. https://doi.org/10.1002/eji.200737772
Ding Q, Xia Y, Ding S, et al (2016) Potential role of CXCL9 induced by endothelial cells/CD133+ liver cancer cells co-culture system in tumor transendothelial migration. Genes Cancer 7:254–259. https://doi.org/https://doi.org/10.18632/genesandcancer.116
Ding S, Li H, Li X et al (2017) Serum amyloid P down-regulates CCL-1 expression, and inhibits Ras/MAPK signaling and development of breast cancer. Trop J Pharm Res 16:2089–2095. https://doi.org/10.4314/tjpr.v16i9.7
Ding M, He S-J, Yang J (2019) MCP-1/CCL2 mediated by autocrine loop of PDGF-BB promotes invasion of lung cancer cell by recruitment of macrophages Via CCL2-CCR2 Axis. J Interferon Cytokine Res 39:224–232. https://doi.org/10.1089/jir.2018.0113
Do HTT, Lee CH, Cho J (2020) Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers. Cancers. https://doi.org/10.3390/cancers12020287
Dufour JH, Dziejman M, Liu MT et al (2002) IFNγ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168:3195–3204. https://doi.org/10.4049/jimmunol.168.7.3195
Fang QI, Wang X, Luo G, et al (2017) Increased CXCL8 expression is negatively correlated with the overall survival of patients with er-negative breast cancer. Anticancer Res 37:4845–4852. https://doi.org/https://doi.org/10.21873/anticanres.11892
Fang T, Lv H, Lv G et al (2018) Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun 9:191. https://doi.org/10.1038/s41467-017-02583-0
Farmaki E, Chatzistamou I, Kaza V, Kiaris H (2016) A CCL8 gradient drives breast cancer cell dissemination. Oncogene 35:6309–6318. https://doi.org/10.1038/onc.2016.161
Feng R, Morine Y, Ikemoto T et al (2018a) Nab-paclitaxel interrupts cancer-stromal interaction through C-X-C motif chemokine 10-mediated interleukin-6 downregulation in vitro. Cancer Sci 109:2509–2519. https://doi.org/10.1111/cas.13694
Feng W, Xue T, Huang S et al (2018b) HIF-1α promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8-NF-κB axis. Cell Mol Biol Lett 23:26. https://doi.org/10.1186/s11658-018-0077-1
Gallo M, Frezzetti D, Roma C, et al (2018) RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells. Oncotarget 9:17543–17553. https://doi.org/https://doi.org/10.18632/oncotarget.24784
Gao D, Cazares LH, Fish EN (2017) CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis. BMC Cancer 17:834. https://doi.org/10.1186/s12885-017-3817-0
Gao H-F, Cheng C-S, Tang J, et al (2020) CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression. Aging 12:502–517. https://doi.org/https://doi.org/10.18632/aging.102638
Gong W, Howard OM, Turpin JA et al (1998) Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J Biol Chem 273:4289–4292. https://doi.org/10.1074/jbc.273.8.4289
Gorbachev AV, Kobayashi H, Kudo D et al (2007) CXC chemokine ligand 9/monokine induced by IFNγ production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors. J Immunol 178:2278–2286. https://doi.org/10.4049/jimmunol.178.4.2278
Guo X, Oshima H, Kitmura T et al (2008) Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J Biol Chem 283:19864–19871. https://doi.org/10.1074/jbc.M800798200
Guo J-C, Li J, Zhou L, et al (2016) CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer. Oncotarget 7:62006–62018. https://doi.org/https://doi.org/10.18632/oncotarget.11330
Guo Z, Chen W, Dai G, Huang Y (2020) Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4. Int J Mol Med 45:141–150. https://doi.org/10.3892/ijmm.2019.4391
Ham SL, Thakuri PS, Plaster M, et al (2018) Three-dimensional tumor model mimics stromal—breast cancer cells signaling. Oncotarget 9:249–267. https://doi.org/https://doi.org/10.18632/oncotarget.22922
Heiskala M, Leidenius M, Joensuu K, Heikkilä P (2019) High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer. Virchows Arch 474:3–12. https://doi.org/10.1007/s00428-018-2461-7
Heneberg P (2016) Paracrine tumor signaling induces transdifferentiation of surrounding fibroblasts. Crit Rev Oncol Hematol 97:303–311. https://doi.org/10.1016/j.critrevonc.2015.09.008
He W, Yang T, Gong X-H et al (2018) Targeting CXC motif chemokine receptor 4 inhibits the proliferation, migration and angiogenesis of lung cancer cells. Oncol Lett 16:3976–3982. https://doi.org/10.3892/ol.2018.9076
Higashino N, Koma Y-I, Hosono M et al (2019) Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma. Lab Invest 99:777–792
Hosono M, Koma Y-I, Takase N, et al (2017) CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells. Oncotarget 8:106071–106088. https://doi.org/https://doi.org/10.18632/oncotarget.22526
Hsu Y-L, Chen Y-J, Chang W-A et al (2018) Interaction between tumor-associated dendritic cells and colon cancer cells contributes to tumor progression via CXCL1. Int J Mol Sci: https://doi.org/10.3390/ijms19082427
Hsu Y-L, Yen M-C, Chang W-A et al (2019) CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB. Breast Cancer Res 21:23. https://doi.org/10.1186/s13058-019-1114-3
Huffman AP, Lin JH, Kim SI et al (2020) CCL5 mediates CD40-driven CD4+ T-cell tumor infiltration and immunity. JCI Insight. https://doi.org/10.1172/jci.insight.137263
Hu Q, Myers M, Fang W et al (2019) Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion. Biol Open. https://doi.org/10.1242/bio.040873
Common Cancer Sites—Cancer Stat Facts. In: SEER. https://seer.cancer.gov/statfacts/html/common.html. Accessed 24 Jul 2020
Irshad S, Flores-Borja F, Lawler K et al (2017) RORγt+ innate lymphoid cells promote lymph node metastasis of breast cancers. Cancer Res 77:1083–1096. https://doi.org/10.1158/0008-5472.CAN-16-0598
Ishii N, Araki K, Yokobori T et al (2019) Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts. Cancer Sci 110:334–344. https://doi.org/10.1111/cas.13847
Jamaludin SYN, Azimi I, Davis FM et al (2018) Assessment of CXC ligand 12-mediated calcium signalling and its regulators in basal-like breast cancer cells. Oncol Lett 15:4289–4295. https://doi.org/10.3892/ol.2018.7827
Janssens R, Struyf S, Proost P (2018a) Pathological roles of the homeostatic chemokine CXCL12. Cytokine Growth Factor Rev 44:51–68. https://doi.org/10.1016/j.cytogfr.2018.10.004
Janssens R, Struyf S, Proost P (2018b) The unique structural and functional features of CXCL12. Cell Mol Immunol 15:299–311. https://doi.org/10.1038/cmi.2017.107
Jian J, Pang Y, Yan HH, et al (2017) Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis. Oncotarget 8:27725–27739. https://doi.org/https://doi.org/10.18632/oncotarget.9486
Jin WJ, Kim B, Kim D et al (2017) NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells. Exp Mol Med 49:e295. https://doi.org/10.1038/emm.2016.148
Ji X, Shen Z, Zhao B et al (2018) CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection. Medicine 97:e0101. https://doi.org/10.1097/MD.0000000000010101
Jung K, Heishi T, Incio J et al (2017) Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer. Proc Natl Acad Sci U S A 114:10455–10460. https://doi.org/10.1073/pnas.1710754114
Kalpana G, Figy C, Yeung M, Yeung KC (2019) Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling. Sci Rep 9:16351. https://doi.org/10.1038/s41598-019-52746-w
Kasashima H, Yashiro M, Nakamae H et al (2016) CXCL1-Chemokine (C-X-C Motif) receptor 2 signaling stimulates the recruitment of bone marrow-derived mesenchymal cells into diffuse-type gastric cancer stroma. Am J Pathol 186:3028–3039. https://doi.org/10.1016/j.ajpath.2016.07.024
Kasashima H, Yashiro M, Nakamae H et al (2017) Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma. PLoS ONE 12:e0178635. https://doi.org/10.1371/journal.pone.0178635
Kersten K, Coffelt SB, Hoogstraat M et al (2017) Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages. Oncoimmunology 6:e1334744. https://doi.org/10.1080/2162402X.2017.1334744
Kikuchi N, Ye J, Hirakawa J, Kawashima H (2019) Forced expression of CXCL10 prevents liver metastasis of colon carcinoma cells by the recruitment of natural killer cells. Biol Pharm Bull 42:57–65. https://doi.org/10.1248/bpb.b18-00538
Kistner L, Doll D, Holtorf A, et al (2017) Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer. Oncotarget 8:89998–90012. https://doi.org/https://doi.org/10.18632/oncotarget.21286
Kuehnemuth B, Piseddu I, Wiedemann GM et al (2018) CCL1 is a major regulatory T cell attracting factor in human breast cancer. BMC Cancer 18:1278. https://doi.org/10.1186/s12885-018-5117-8
Kundu N, Ma X, Brox R et al (2019) The chemokine Receptor CXCR3 isoform B drives breast cancer stem cells. Breast Cancer 13:1178223419873628. https://doi.org/10.1177/1178223419873628
Lacalle RA, Blanco R, Carmona-Rodríguez L et al (2017) Chemokine receptor signaling and the hallmarks of cancer. Int Rev Cell Mol Biol 331:181–244. https://doi.org/10.1016/bs.ircmb.2016.09.011
Larsen CG, Anderson AO, Appella E et al (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464–1466. https://doi.org/10.1126/science.2648569
Lee H-H, Farber JM (1996) Localization of the gene for the human MIG cytokine on chromosome 4q21 adjacent to INP10 reveals a chemokine “mini-cluster.” Cytogenet Genome Res 74:255–258. https://doi.org/10.1159/000134428
Lee S, Lee E, Ko E et al (2018) Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-α and MMP-9. Cancer Lett 437:25–34. https://doi.org/10.1016/j.canlet.2018.08.025
Le Naour A, Prat M, Thibault B, et al (2018) Mesenchymal stromal cells release CXCL1/2/8 and induce chemoresistance and macrophage polarization. bioRxiv 482513
Lesina M, Wörmann SM, Morton J et al (2016) RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest 126:2919–2932. https://doi.org/10.1172/JCI86477
Liubomirski Y, Lerrer S, Meshel T et al (2019a) Notch-mediated tumor-stroma-inflammation networks promote invasive properties and CXCL8 expression in triple-negative breast cancer. Front Immunol 10:804. https://doi.org/10.3389/fimmu.2019.00804
Liubomirski Y, Lerrer S, Meshel T et al (2019b) Tumor-stroma-inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer. Front Immunol 10:757. https://doi.org/10.3389/fimmu.2019.00757
Liu J, Chen S, Wang W et al (2016) Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways. Cancer Lett 379:49–59. https://doi.org/10.1016/j.canlet.2016.05.022
Liu Y, Zhang J, Sun X, et al (2017) Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer. Oncotarget 8:39559–39570. https://doi.org/https://doi.org/10.18632/oncotarget.17136
Liu Y, Zheng H, Li Q et al (2019b) Discovery of CCL18 antagonist blocking breast cancer metastasis. Clin Exp Metastasis 36:243–255. https://doi.org/10.1007/s10585-019-09965-2
Liu L, Sun H, Wu S et al (2019a) IL-17A promotes CXCR2-dependent angiogenesis in a mouse model of liver cancer. Mol Med Rep 20:1065–1074. https://doi.org/10.3892/mmr.2019.10310
Liu Q, Song J, Pan Y et al (2020) Wnt5a/CaMKII/ERK/CCL2 axis is required for tumor-associated macrophages to promote colorectal cancer progression. Int J Biol Sci 16:1023–1034. https://doi.org/10.7150/ijbs.40535
Li J, Liu Q, Huang X et al (2019a) Transcriptional profiling reveals the regulatory role of CXCL8 in promoting colorectal cancer. Front Genet 10:1360. https://doi.org/10.3389/fgene.2019.01360
Li X, Wang L, Fang P et al (2018) Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation. J Biol Chem 293:11033–11045. https://doi.org/10.1074/jbc.RA118.002752
Li Z, Zhou J, Zhang J et al (2019c) Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5. Int J Cancer 17:1. https://doi.org/10.1002/ijc.32278
Li J, Yang C, Yang J, Zou L (2019b) Down-regulation of CCL17 in cancer-associated fibroblasts inhibits cell migration and invasion of breast cancer through ERK1/2 pathway. Cancer Manag Res 11:7439–7453. https://doi.org/10.2147/CMAR.S211651
Li D, Ji H, Niu X et al (2020) Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer. Cancer Sci 111:47–58. https://doi.org/10.1111/cas.14230
Lohmann-Matthes ML (1989) Interaction of macrophages and cytokines. Curr Opin Immunol 2:33–38. https://doi.org/10.1016/0952-7915(89)90094-0
Lorenzen E, Dodig-Crnković T, Kotliar IB, et al (2019) Multiplexed analysis of the secretin-like GPCR-RAMP interactome. Sci Adv 5:eaaw2778. https://doi.org/https://doi.org/10.1126/sciadv.aaw2778
Loveridge CJ, Mui EJ, Patel R et al (2017) Increased T-cell infiltration Elicited by Erk5 deletion in a Pten-deficient mouse model of prostate carcinogenesis. Cancer Res 77:3158–3168. https://doi.org/10.1158/0008-5472.CAN-16-2565
Luster AD, Unkeless JC, Ravetch JV (1985) Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672–676. https://doi.org/10.1038/315672a0
Lu J, Chatterjee M, Schmid H et al (2016) CXCL14 as an emerging immune and inflammatory modulator. J Inflamm 13:1. https://doi.org/10.1186/s12950-015-0109-9
Maghazachi AA, Al-Aoukaty A, Schall TJ (1996) CC chemokines induce the generation of killer cells from CD56+ cells. Eur J Immunol 26:315–319. https://doi.org/10.1002/eji.1830260207
Mano Y, Yoshio S, Shoji H et al (2019) Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma. J Gastroenterol 54:1007–1018. https://doi.org/10.1007/s00535-019-01579-5
Mantovani A, Bottazzi B, Sozzani S, et al (1993) Cytokine regulation of tumour-associated macrophages. Res Immunol 144:280–3; discussion 294–8. https://doi.org/https://doi.org/10.1016/0923-2494(93)80108-b
Marcuzzi E, Angioni R, Molon B, Calì B (2018) Chemokines and chemokine receptors: orchestrating tumor metastasization. Int J Mol Sci: https://doi.org/10.3390/ijms20010096
Martinez-Ordoñez A, Seoane S, Cabezas P et al (2018) Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis. Oncogene 37:1430–1444. https://doi.org/10.1038/s41388-017-0036-8
Mateo FNL (2019) The role of chemokine (cc motif) ligand 2 in inflammation, oxidative stress, aging and metabolism. Universitat Rovira i Virgili
Maurer A-M, Zhou B, Han ZC (2006) Roles of platelet factor 4 in hematopoiesis and angiogenesis. Growth Factors 24:242–252. https://doi.org/10.1080/08977190600988225
Ma B, Khazali A, Wells A (2015) CXCR3 in carcinoma progression. Histol Histopathol 30:781–792. https://doi.org/https://doi.org/10.14670/HH-11-594
Ma J-C, Sun X-W, Su H et al (2017) Fibroblast-derived CXCL12/SDF-1α promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K/Akt/mTOR pathway in colon cancer. World J Gastroenterol 23:5167–5178. https://doi.org/10.3748/wjg.v23.i28.5167
Ma J, Su H, Yu B et al (2018) CXCL12 gene silencing down-regulates metastatic potential via blockage of MAPK/PI3K/AP-1 signaling pathway in colon cancer. Clin Transl Oncol 20:1035–1045. https://doi.org/10.1007/s12094-017-1821-0
Meng W, Xue S, Chen Y (2018) The role of CXCL12 in tumor microenvironment. Gene 641:105–110. https://doi.org/10.1016/j.gene.2017.10.015
Mirzaei H, Salehi H, Oskuee RK et al (2018) The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model. Cancer Lett 419:30–39. https://doi.org/10.1016/j.canlet.2018.01.029
Miyake M, Hori S, Morizawa Y et al (2016) CXCL1-mediated interaction of cancer cells with tumor-associated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer. Neoplasia 18:636–646. https://doi.org/10.1016/j.neo.2016.08.002
Mollica Poeta V, Massara M, Capucetti A, Bonecchi R (2019) Chemokines and chemokine receptors: new targets for cancer immunotherapy. Front Immunol 10:379. https://doi.org/10.3389/fimmu.2019.00379
Moore-Smith LD, Isayeva T, Lee JH et al (2017) Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment. Sci Rep 7:8678. https://doi.org/10.1038/s41598-017-09062-y
Mueller SN, Germain RN (2009) Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 9:618–629. https://doi.org/10.1038/nri2588
Nagasawa T, Hirota S, Tachibana K et al (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635–638. https://doi.org/10.1038/382635a0
Naito Y, Yamamoto Y, Sakamoto N et al (2019) Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts. Oncogene 38:5566–5579. https://doi.org/10.1038/s41388-019-0832-4
Nakatsumi H, Matsumoto M, Nakayama KI (2017) Noncanonical pathway for regulation of CCL2 expression by an mTORC1-FOXK1 axis promotes recruitment of tumor-associated macrophages. Cell Rep 21:2471–2486. https://doi.org/10.1016/j.celrep.2017.11.014
Nguyen AH, Elliott IA, Wu N, et al (2017) Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. Oncotarget 8:19074–19088. https://doi.org/https://doi.org/10.18632/oncotarget.13572
Nishikawa G, Kawada K, Nakagawa J et al (2019) Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5. Cell Death Dis 10:264. https://doi.org/10.1038/s41419-019-1508-2
Nishina S, Yamauchi A, Kawaguchi T et al (2019) Dipeptidyl Peptidase 4 inhibitors reduce hepatocellular carcinoma by activating lymphocyte chemotaxis in mice. Cell Mol Gastroenterol Hepatol 7:115–134. https://doi.org/10.1016/j.jcmgh.2018.08.008
O’Donovan N, Galvin M, Morgan JG (1999) Physical mapping of the CXC chemokine locus on human chromosome 4. Cytogenet Cell Genet 84:39–42. https://doi.org/10.1159/000015209
Obr AE, Kumar S, Chang Y-J et al (2018) Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment. Breast Cancer Res 20:138. https://doi.org/10.1186/s13058-018-1063-2
Pan H, Peng Z, Lin J et al (2018) Forkhead box C1 boosts triple-negative breast cancer metastasis through activating the transcription of chemokine receptor-4. Cancer Sci 109:3794–3804. https://doi.org/10.1111/cas.13823
Pasquier J, Gosset M, Geyl C et al (2018) CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer. Mol Cancer 17:47. https://doi.org/10.1186/s12943-018-0787-z
Pausch TM, Aue E, Wirsik NM et al (2020) Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes. Sci Rep 10:5420. https://doi.org/10.1038/s41598-020-62416-x
Pein M, Insua-Rodríguez J, Meier J, et al (2019) CXCR3-expressing metastasis-initiating cells induce and exploit a fibroblast niche in the lungs to fuel metastatic colonization. bioRxiv 546952
Peranzoni E, Donnadieu E (2019) Improving efficacy of cancer immunotherapy through targeting of macrophages. Hum Vaccin Immunother 15:189–192. https://doi.org/10.1080/21645515.2018.1515447
Persson T, Monsef N, Andersson P et al (2003) Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils. Clin Exp Allergy 33:531–537. https://doi.org/10.1046/j.1365-2222.2003.01609.x
Pisabarro MT, Leung B, Kwong M et al (2006) Cutting edge: novel human dendritic cell- and monocyte-attracting chemokine-like protein identified by fold recognition methods. J Immunol 176:2069–2073. https://doi.org/10.4049/jimmunol.176.4.2069
Plaster M, Singh S, Tavana H (2019) Fibroblasts promote proliferation and matrix invasion of breast cancer cells in co-culture models. Adv Ther 2:1900121. https://doi.org/10.1002/adtp.201900121
Proost P, Wuyts A, Conings R et al (1993) Human and bovine granulocyte chemotactic protein-2: complete amino acid sequence and functional characterization as chemokines. Biochemistry 32:10170–10177. https://doi.org/10.1021/bi00089a037
Proost P, Wuyts A, Van Damme J (1996) Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol 59:67–74. https://doi.org/10.1002/jlb.59.1.67
Pucci F, Rickelt S, Newton AP et al (2016) PF4 Promotes platelet production and lung cancer growth. Cell Rep 17:1764–1772. https://doi.org/10.1016/j.celrep.2016.10.031
Qian T, Liu Y, Dong Y et al (2018) CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro. Mol Med Rep 17:3633–3639. https://doi.org/10.3892/mmr.2017.8286
Raman D, Baugher PJ, Thu YM, Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256:137–165. https://doi.org/10.1016/j.canlet.2007.05.013
Razis E, Kalogeras KT, Kotsantis I et al (2020) The Role of CXCL13 and CXCL9 in early breast cancer. Clin Breast Cancer 20:e36–e53. https://doi.org/10.1016/j.clbc.2019.08.008
Ren J, Smid M, Iaria J et al (2019) Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. Breast Cancer Res 21:109. https://doi.org/10.1186/s13058-019-1194-0
Reymond N, d’Água BB, Ridley AJ (2013) Crossing the endothelial barrier during metastasis. Nat Rev Cancer 13:858–870. https://doi.org/10.1038/nrc3628
Richmond A, Thomas HG (1988) Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution. J Cell Biochem 36:185–198. https://doi.org/10.1002/jcb.240360209
Rowland KJ, Diaz-Miron J, Guo J, et al (2014) CXCL5 is required for angiogenesis, but not structural adaptation after small bowel resection. J Pediatr Surg 49:976–80; discussion 980. https://doi.org/https://doi.org/10.1016/j.jpedsurg.2014.01.034
Salmon H, Franciszkiewicz K, Damotte D et al (2012) Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest 122:899–910. https://doi.org/10.1172/JCI45817
Sano M, Ijichi H, Takahashi R et al (2019) Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment. Oncogenesis 8:8. https://doi.org/10.1038/s41389-018-0117-8
Schraufstatter IU, Zhao M, Khaldoyanidi SK, Discipio RG (2012) The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum. Immunology 135:287–298. https://doi.org/10.1111/j.1365-2567.2011.03541.x
Schwenk R, Stehning T, Bischoff I, et al (2017) The pretubulysin-induced exposure of collagen is caused by endothelial cell retraction that results in an increased adhesion and decreased transmigration of tumor cells. Oncotarget 8:77622–77633. https://doi.org/https://doi.org/10.18632/oncotarget.20746
Shen T, Yang Z, Cheng X et al (2017) CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway. Oncol Rep 37:2095–2100. https://doi.org/10.3892/or.2017.5453
Shen Q, Fan X, Jiang M et al (2019) Inhibiting expression of Cxcl9 promotes angiogenesis in MSCs-HUVECs co-culture. Arch Biochem Biophys 675:108108. https://doi.org/10.1016/j.abb.2019.108108
Shore DM, Reggio PH (2015) The therapeutic potential of orphan GPCRs, GPR35 and GPR55. Front Pharmacol 6:69. https://doi.org/10.3389/fphar.2015.00069
Sjöberg E, Meyrath M, Milde L et al (2019) A novel ACKR2-dependent role of fibroblast-derived CXCL14 in epithelial-to-mesenchymal transition and metastasis of breast cancer. Clin Cancer Res 25:3702–3717. https://doi.org/10.1158/1078-0432.CCR-18-1294
Sjöberg E, Meyrath M, Chevigné A et al (2020) The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy. Adv Cancer Res 145:99–138. https://doi.org/10.1016/bs.acr.2019.12.001
Song Z-Y, Wang F, Cui S-X, Qu X-J (2018) Knockdown of CXCR4 inhibits CXCL12-induced angiogenesis in huvecs through downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-catenin pathways. Cancer Invest 36:10–18. https://doi.org/10.1080/07357907.2017.1422512
Stoeckle MY, Barker KA (1990) Two burgeoning families of platelet factor 4-related proteins: mediators of the inflammatory response. New Biol 2:313–323
Stone MJ, Hayward JA, Huang C et al (2017) Mechanisms of regulation of the chemokine-receptor network. Int J Mol Sci. https://doi.org/10.3390/ijms18020342
Sun X, Glynn DJ, Hodson LJ et al (2017) CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model. Breast Cancer Res 19:4. https://doi.org/10.1186/s13058-016-0796-z
Sun Z, Du C, Xu P, Miao C (2019) Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression. J Cell Physiol 234:4608–4616. https://doi.org/10.1002/jcp.27245
Susek KH, Karvouni M, Alici E, Lundqvist A (2018) The Role of CXC chemokine receptors 1–4 on immune cells in the tumor microenvironment. Front Immunol 9:2159. https://doi.org/10.3389/fimmu.2018.02159
Su S, Liao J, Liu J et al (2017) Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res 27:461–482. https://doi.org/10.1038/cr.2017.34
Tanabe Y, Sasaki S, Mukaida N, Baba T (2016) Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation. Oncotarget 7:48335–48345. https://doi.org/https://doi.org/10.18632/oncotarget.10227
Tang S, Xiang T, Huang S et al (2016) Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling. Cancer Lett 376:137–147. https://doi.org/10.1016/j.canlet.2016.03.034
Tan S, Wang K, Sun F et al (2018) CXCL9 promotes prostate cancer progression through inhibition of cytokines from T cells. Mol Med Rep 18:1305–1310. https://doi.org/10.3892/mmr.2018.9152
Tejchman A, Lamerant-Fayel N, Jacquinet J-C, et al (2017) Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization. Oncotarget 8:31876–31887. https://doi.org/https://doi.org/10.18632/oncotarget.16311
Tivari S, Lu H, Dasgupta T et al (2018) Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence. Cell Commun Signal 16:48. https://doi.org/10.1186/s12964-018-0259-5
Tokunaga R, Zhang W, Naseem M et al (2018) CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev 63:40–47. https://doi.org/10.1016/j.ctrv.2017.11.007
Truffi M, Sorrentino L, Corsi F (2020) Fibroblasts in the tumor microenvironment. Adv Exp Med Biol 1234:15–29. https://doi.org/10.1007/978-3-030-37184-5_2
Tsai C-F, Chen J-H, Yeh W-L (2019) Pulmonary fibroblasts-secreted CXCL10 polarizes alveolar macrophages under pro-inflammatory stimuli. Toxicol Appl Pharmacol 380:114698. https://doi.org/10.1016/j.taap.2019.114698
Uddin MM, Gaire B, Vancurova I (2020) Interleukin-8 induces proliferation of ovarian cancer cells in 3D spheroids. Methods Mol Biol 2108:117–124. https://doi.org/10.1007/978-1-0716-0247-8_10
Walens A, DiMarco AV, Lupo R et al (2019) CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors. Elife. https://doi.org/10.7554/eLife.43653
Wang J, Huang S (2018) Fisetin inhibits the growth and migration in the A549 human lung cancer cell line via the ERK1/2 pathway. Exp Ther Med 15:2667–2673. https://doi.org/10.3892/etm.2017.5666
Wang Y, Liu J, Jiang Q et al (2017b) Human adipose-derived mesenchymal stem cell-secreted CXCL1 and CXCL8 facilitate breast tumor growth by promoting angiogenesis. Stem Cells 35:2060–2070
Wang X, Lang M, Zhao T et al (2017a) Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. Oncogene 36:3048–3058. https://doi.org/10.1038/onc.2016.458
Wang L, Shi L, Gu J et al (2018a) CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells. J Physiol Biochem 74:313–324. https://doi.org/10.1007/s13105-018-0619-z
Wang N, Liu W, Zheng Y et al (2018b) CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling. Cell Death Dis 9:880. https://doi.org/10.1038/s41419-018-0876-3
Wang L, Li H, Zhen Z et al (2019) CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma. Gene 690:129–136. https://doi.org/10.1016/j.gene.2018.12.043
Watanabe K, Suzukawa M, Arakawa S et al (2019) Leptin enhances cytokine/chemokine production by normal lung fibroblasts by binding to leptin receptor. Allergol Int 68S:S3–S8. https://doi.org/10.1016/j.alit.2019.04.002
Watson C, Jenkinson S, Kazmierski W, Kenakin T (2005) The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor. Mol Pharmacol 67:1268–1282. https://doi.org/10.1124/mol.104.008565
Weinstein EJ, Head R, Griggs DW et al (2006) VCC-1, a novel chemokine, promotes tumor growth. Biochem Biophys Res Commun 350:74–81. https://doi.org/10.1016/j.bbrc.2006.08.194
Wen Z, Liu Q, Wu J, et al (2019) Fibroblast activation protein α-positive pancreatic stellate cells promote the migration and invasion of pancreatic cancer by CXCL1-mediated Akt phosphorylation. Ann Transl Med, 7:532. https://doi.org/https://doi.org/10.21037/atm.2019.09.164
Wolpe SD, Davatelis G, Sherry B et al (1988) Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167:570–581. https://doi.org/10.1084/jem.167.2.570
Wuyts A, Van Osselaer N, Haelens A et al (1997) Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 36:2716–2723. https://doi.org/10.1021/bi961999z
Wu H, Zhang X, Han D et al (2020a) Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8. PeerJ 8:e8721. https://doi.org/10.7717/peerj.8721
Wu L, Awaji M, Saxena S et al (2020b) IL-17-CXC Chemokine receptor 2 Axis facilitates breast cancer progression by up-regulating neutrophil recruitment. Am J Pathol 190:222–233. https://doi.org/10.1016/j.ajpath.2019.09.016
Xu Y, Dong X, Qi P et al (2017) Sox2 communicates with tregs through CCL1 to promote the stemness property of breast cancer cells. Stem Cells 35:2351–2365. https://doi.org/10.1002/stem.2720
Yang L, Hong Q, Xu S-G et al (2019b) Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor-κB signaling pathway. Mol Med Rep 20:4045–4258. https://doi.org/10.3892/mmr.2019.10643
Yang X, Lin Y, Shi Y et al (2016) fap promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3–CCL2 signaling. Cancer Res 76:4124–4135. https://doi.org/10.1158/0008-5472.CAN-15-2973
Yang T, Chen M, Yang X et al (2017) Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis. Cancer Biol Ther 18:806–815. https://doi.org/10.1080/15384047.2017.1373219
Yang C, Yu H, Chen R et al (2019a) CXCL1 stimulates migration and invasion in ER-negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis. Int J Oncol 55:684–696. https://doi.org/10.3892/ijo.2019.4840
Yao M, Smart C, Hu Q, Cheng N (2017) Continuous delivery of neutralizing antibodies elevate CCL2 levels in mice bearing MCF10CA1d breast tumor xenografts. Transl Oncol 10:734–743. https://doi.org/10.1016/j.tranon.2017.06.009
Yao M, Fang W, Smart C et al (2019) CCR2 Chemokine receptors enhance growth and cell-cycle progression of breast cancer cells through SRC and PKC activation. Mol Cancer Res 17:604–617. https://doi.org/10.1158/1541-7786.MCR-18-0750
Yasumoto K, Okamoto S-I, Mukaida N et al (1992) Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J Biol Chem 267:22506–22511
Yeh C-R, Slavin S, Da J et al (2016) Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment. Mol Cancer 15:7. https://doi.org/10.1186/s12943-015-0488-9
Yin Z, Huang J, Ma T et al (2017) Macrophages activating chemokine (C-X-C motif) ligand 8/miR-17 cluster modulate hepatocellular carcinoma cell growth and metastasis. Am J Transl Res 9:2403–2411
Yuan M, Zhu H, Xu J et al (2016) Tumor-derived CXCL1 promotes lung cancer growth via recruitment of tumor-associated neutrophils. J Immunol Res 2016:6530410. https://doi.org/10.1155/2016/6530410
Yu PF, Huang Y, Han YY et al (2017a) TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene 36:482–490. https://doi.org/10.1038/onc.2016.217
Yu PF, Huang Y, Xu CL et al (2017b) Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis. Oncogene 36:840–849. https://doi.org/10.1038/onc.2016.252
Yu Z, Han-Bo CAO, Wen-Jun LI, Li Z (2018) The CXCL12 (SDF-1)/CXCR4 chemokine axis: oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy. Chin J Nat Med 16:801–810
Yu L, Pham Q, Yu LL, Wang TTY (2020) Modulation of CXC-motif chemokine receptor 7, but not 4, expression is related to migration of the human prostate cancer cell LNCaP: regulation by androgen and inflammatory stimuli. Inflamm Res 69:167–178. https://doi.org/10.1007/s00011-019-01305-0
Zeng Y, Wang X, Yin B, et al (2017) Role of the stromal cell derived factor-1/CXC chemokine receptor 4 axis in the invasion and metastasis of lung cancer and mechanism. J Thorac Dis 9:4947–4959. https://doi.org/https://doi.org/10.21037/jtd.2017.10.138
Zhang M, Ding G, Zhou L et al (2018a) Interferon gamma inhibits CXCL8-induced proliferation and migration of pancreatic cancer BxPC-3 cell line via a RhoGDI2/Rac1/NF-κB signaling pathway. J Interferon Cytokine Res 38:413–422. https://doi.org/10.1089/jir.2018.0070
Zhang W, Wu Q, Wang C et al (2018b) AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells. Mol Cell Biochem 448:311–320. https://doi.org/10.1007/s11010-018-3335-7
Zhang Z, Tan X, Luo J et al (2018c) GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells. Cancer Med 7:5611–5620. https://doi.org/10.1002/cam4.1783
Zhang M, Huang L, Ding G et al (2020) Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. J Immunother Cancer. https://doi.org/10.1136/jitc-2019-000308
Zhao J, Ou B, Han D et al (2017) Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. Mol Cancer 16:70. https://doi.org/10.1186/s12943-017-0629-4
Zhao W, Ajani JA, Sushovan G et al (2018) Galectin-3 mediates tumor cell-stroma interactions by activating pancreatic stellate cells to produce cytokines via integrin signaling. Gastroenterology 154:1524-1537.e6. https://doi.org/10.1053/j.gastro.2017.12.014
Zhao C, Zheng S, Yan Z et al (2020) CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2. Oncol Rep 43:571–580. https://doi.org/10.3892/or.2019.7426
Zheng Y-W, Ma M-Z, Xu Y-T et al (2016) CXCL6 is upregulated in hepatocellular carcinoma and promotes invasion of liver cancer cells via targeting MMP9. Int J Clin Exp Pathol 9:4661–4672
Zhou W, Guo S, Liu M et al (2019) Targeting CXCL12/CXCR4 axis in tumor immunotherapy. Curr Med Chem 26:3026–3041. https://doi.org/10.2174/0929867324666170830111531
Zhu Y, Zhang L, Zha H et al (2017) Stroma-derived fibrinogen-like protein 2 activates cancer-associated fibroblasts to promote tumor growth in lung cancer. Int J Biol Sci 13:804–814. https://doi.org/10.7150/ijbs.19398
Zhu W-B, Zhao Z-F, Zhou X (2019) AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer. J Cell Physiol 234:11746–11759. https://doi.org/10.1002/jcp.27831
Zhu Q, Zhang Z, Lu C et al (2020) Gefitinib promotes CXCR4-dependent epithelial to mesenchymal transition via TGF-β1 signaling pathway in lung cancer cells harboring EGFR mutation. Clin Transl Oncol. https://doi.org/10.1007/s12094-019-02266-w
Ziegler ME, Hatch MMS, Wu N et al (2016) mTORC2 mediates CXCL12-induced angiogenesis. Angiogenesis 19:359–371. https://doi.org/10.1007/s10456-016-9509-6
Zuo J, Wen M, Li S et al (2017) Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9. Oncol Lett 14:7513–7521. https://doi.org/10.3892/ol.2017.7168
Funding
Funding for this review was provided by OCSSB at Oregon Health and Sciences University, and by the 2019 PhRMA Foundation post-doctoral fellowship in translational medicine and therapeutics
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Singh, A.J., Gray, J.W. Chemokine signaling in cancer-stroma communications. J. Cell Commun. Signal. 15, 361–381 (2021). https://doi.org/10.1007/s12079-021-00621-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-021-00621-7